Cargando…

The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio, Deemed the Nephron Index, Is a Useful Clinical Index for Early Stage Chronic Kidney Disease in Patients with Type 2 Diabetes: An Observational Pilot Study

Renal function decline is associated with progressive type 2 diabetes mellitus, which causes mineral and bone disorders. In the present study, we defined the ratio of urinary phosphate excretion (mg/day) to serum fibroblast growth factor 23 as the nephron index. We examined changes in the nephron in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Hodaka, Kuro-o, Makoto, Funazaki, Shunsuke, Ishikawa, San-e, Kakei, Masafumi, Hara, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139210/ https://www.ncbi.nlm.nih.gov/pubmed/30245879 http://dx.doi.org/10.1155/2018/7530923

Ejemplares similares

The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease
por: Yamada, Hodaka, et al.
Publicado: (2016)

Diabetic ketoacidosis producing extreme hyperkalemia in a patient with type 1 diabetes on hemodialysis
por: Yamada, Hodaka, et al.
Publicado: (2017)

Association between Urinary Calcium Excretion and Estimated Glomerular Filtration Rate Decline in Patients with Type 2 Diabetes Mellitus: A Retrospective Single-center Observational Study
por: Yamada, Hodaka, et al.
Publicado: (2018)

Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report
por: Matsumoto, Yuko, et al.
Publicado: (2017)

Spontaneous pregnancy after full recovery from hypopituitarism caused by lymphocytic hypophysitis
por: Funazaki, Shunsuke, et al.
Publicado: (2018)

A novel mechanism of imeglimin‐mediated insulin secretion via the cADPR‐TRP channel pathway
por: Funazaki, Shunsuke, et al.
Publicado: (2021)

Pseudo Intestinal Obstruction Caused by Malignant Paraganglioma
por: Funazaki, Shunsuke, et al.
Publicado: (2021)

Relationship Between Angiopoietin-Like Protein 8 and Fasting Serum Triglyceride Level
por: Yamada, Hodaka, et al.
Publicado: (2018)

Effects of Repaglinide Versus Glimepiride on 1,5-Anhydroglucutol and Glycated Hemoglobin Levels in Japanese Patients With Type 2 Diabetes
por: Yamada, Hodaka, et al.
Publicado: (2018)

Eicosapentaenoic acid shows anti-inflammatory effect via GPR120 in 3T3-L1 adipocytes and attenuates adipose tissue inflammation in diet-induced obese mice
por: Yamada, Hodaka, et al.
Publicado: (2017)

Sodium–glucose cotransporter 2 inhibitors improved time‐in‐range without increasing hypoglycemia in Japanese patients with type 1 diabetes: A retrospective, single‐center, pilot study
por: Suzuki, Daisuke, et al.
Publicado: (2020)

Case of fulminant type 1 diabetes with coronary microcirculatory dysfunction
por: Yamada, Hodaka, et al.
Publicado: (2014)

Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study
por: Yamada, Hodaka, et al.
Publicado: (2022)

Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study
por: Yamada, Hodaka, et al.
Publicado: (2023)

Retrospective Study of IDegLira, a New Fixed-Ratio Combination, in Japanese Patients With Type 2 Diabetes Mellitus: Analysis of Background Factors Affecting Effectiveness After 6 Months of Treatment
por: Yamada, Hodaka, et al.
Publicado: (2023)

Risk Factors of Hypoglycemic Encephalopathy and Prolonged Hypoglycemia in Patients With Severe Hypoglycemia
por: Saikawa, Rika, et al.
Publicado: (2019)

Potentiation of Glucose-stimulated Insulin Secretion by the GPR40–PLC–TRPC Pathway in Pancreatic β-Cells
por: Yamada, Hodaka, et al.
Publicado: (2016)

Background Factors Determining the Introduction and Dosage of Insulin in Women With Gestational Diabetes Mellitus
por: Matsumoto, Yuko, et al.
Publicado: (2019)

Spontaneous recovery of immune checkpoint inhibitor‐induced thyroiditis with high free T4 level: A case report
por: Hagiwara, Rie, et al.
Publicado: (2021)

Retrospective Analysis of the Effectiveness of Oral Semaglutide in Type 2 Diabetes Mellitus and Its Effect on Cardiometabolic Parameters in Japanese Clinical Settings
por: Yamada, Hodaka, et al.
Publicado: (2023)

Phosphate and Klotho
por: Kuro-o, Makoto
Publicado: (2011)

Calciprotein particles and fibroblast growth factor 23 contribute to the pathophysiology of hypercalcemia in a patient with renal sarcoidosis
por: Iwazu, Yoshitaka, et al.
Publicado: (2019)

Second Symposium Deemed a Success
por: Booker, Susan M.
Publicado: (1998)

Large Hadron Collider deemed safe
Publicado: (2008)

Large Hadron Collider deemed safe
Publicado: (2008)

Large Hadron Collider deemed safe
Publicado: (2008)

Large Hadron Collider deemed safe
Publicado: (2008)

Deemed consent for deceased organ donation
por: Weiss, Matthew J., et al.
Publicado: (2021)

Receiving or not deemed necessary healthcare services
por: Sulku, Seher Nur, et al.
Publicado: (2023)

Nephron index rather than serum FGF 23 predicts endothelial dysfunction in early but not advanced chronic kidney disease patients
por: Khreba, Nora, et al.
Publicado: (2023)

Hypereosinophilia is a predictive biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma
por: Yamada, Hodaka, et al.
Publicado: (2022)

Phosphate as a Pathogen of Arteriosclerosis and Aging
por: Kuro-o, Makoto
Publicado: (2021)

Deemed consent for organ donation in Northern Ireland
por: Parsons, Jordan A., et al.
Publicado: (2021)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
por: Ghorbanihaghjo, Amir, et al.
Publicado: (2018)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease
por: Kuro-o, Makoto
Publicado: (2013)

Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression
por: Kuro-o, Makoto
Publicado: (2023)

Big Bang project deemed a big success
Publicado: (2008)

Antibacterial resistance deemed a public-health crisis
por: Larkin, Marilynn
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_jind13ufulqp56re5tu0ihu8k1